House Republicans are urging President Trump to use executive action on COVID-19 mandates for organ transplants.
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...
House Bill 522 would make it illegal to block organ transplants for those in need solely due to their COVID vaccination ...
Novavax is starting to look like a vaccine development company again. And 2025 stands to be a big year for the local biotech.
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...
Robert F. Kennedy Jr, the newly confirmed health secretary for the Trump administration who has called for sweeping policy ...
The meeting cancellation came one day before the CDC issued its weekly MMWR report, a scientific update on the latest ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
Donald Trump might as well set up a merch booth in the Oval Office. The president, accompanied by Health Secretary Robert F. Kennedy Jr. and Commerce Secretary Howard Lutnick, decided to hawk some new ...